‘I thought I could run it off,’ says boy, 16, forced to have leg amputated after rugby tackle revealed aggressive cancer
WHEN Oliver Liddle’s knee started to hurt after a game of rugby, he assumed it was from a dodgy tackle. The then-12-year-old ...
Stay vigilant for signs of aggressive cancer that's typically missed
Woman, 33, battled 'gluten intolerance' for months - it was cancerBrits were today urged to watch out for frequently ...
3dnatives.com15d
3D Printed Implants for Tumor Treatment in Children
Professor Anamika Prasad from Florida International University developed 3D-printed implants in the form of scaffold ...
Frontiers18d
Gelatin-based biomaterials as a delivery strategy for osteosarcoma treatment
Osteosarcoma is the most common primary malignant bone tumor. Although surgery and chemoradiotherapy have made some progress in the treatment of osteosarcoma. However, the high recurrence and ...
Frontiers24d
Progress in immune microenvironment, immunotherapy and prognostic biomarkers in pediatric osteosarcoma
1 Department of Orthopedics, The Third Affiliated Hospital of Shenzhen University, Shenzhen, China 2 Department of Pediatrics, Shenzhen University General Hospital, Shenzhen, China Pediatric ...
ENDPOINTS NEWS29d
On­col­o­gy biotech plots ex­pe­dit­ed ap­proval for bone can­cer drug af­ter Phase 2 win
OS Ther­a­pies is mov­ing ahead with plans for an ac­cel­er­at­ed ap­proval path­way af­ter its off-the-shelf can­di­date for peo­ple who have had surgery to treat os­teosar­co­ma … ...
Business Wire29d
OS Therapies Announces Phase 2b Clinical Trial of OST-HER2 Achieves Primary Endpoint with Statistical Significance in the Prevention of Recurrent, Fully Resected, Lung ...
The US FDA granted OST-HER2 rare pediatric disease designation for osteosarcoma in 2021. The US FDA rare pediatric disease PRV program aims to incentivize drug development for rare pediatric diseases.